Insights into the clinical studies related to cardiovascular surgery from the American Heart Association’s Scientific Sessions 2021: Part one
- VernacularTitle:2021年美国心脏学会心血管外科热点研究解读（一）
- Author:
Yi YANG
1
;
Jiaxi ZHU
1
;
Yunpeng ZHU
1
;
Qiang ZHAO
1
Author Information
1. Department of Cardiovascular Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, P. R. China
- Publication Type:Journal Article
- Keywords:
American Heart Association;
atrial fibrillation;
vascular endothelial growth factor;
external stent for vein graft;
interpretation
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2022;29(04):407-410
- CountryChina
- Language:Chinese
-
Abstract:
In the American Heart Association’s Scientific Sessions 2021, the results of six clinical trials related to cardiovascular surgery were revealed. The PALACS trial demonstrated that posterior left pericardiotomy during open heart surgery was associated with a significant reduction in postoperative atrial fibrillation; the EPICCURE study found that injection of mRNA encoding vascular endothelial growth factor (VEGF-A mRNA) directly into the myocardium of patients undergoing elective coronary artery bypass grafting (CABG) improved patients’ heart function; the VEST trial once again proved the safety and potential value of external stent for vein graft. This article will interpret the above-mentioned three studies.
